Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1994-8-9
|
pubmed:abstractText |
Ecto-5'-nucleotidase (5'-NT,) CD73 is a glycosyl phosphatidylinositol (GPI)-anchored differentiation Ag and purine salvage enzyme expressed on the surface of subsets of human lymphocytes. CD73 mAbs, in combination with submitogenic PMA or OKT3, activate human T cells to proliferate, secrete IL-2, and express IL-2 receptors. For several GPI-anchored proteins implicated in T cell activation, activation is thought to occur through a mechanism that requires the GPI anchor. To investigate the role of the GPI anchor in CD73-mediated signal transduction, CD73 cDNA was transfected into the human T cell leukemia line Jurkat. Transfectants were stimulated to secrete IL-2 by immobilized OKT3 + PMA and by soluble CD73 mAb + PMA. The amount of IL-2 synthesized by individual clones in response to CD73 mAb + PMA was proportional to the IL-2 response to immobilized OKT3 + PMA. CD73 transfectants of Jurkat mutants defective in the TCR, in p56lck, or in the tyrosine phosphatase CD45 did not secrete IL-2 in response to CD73 mAb + PMA, suggesting a role for the CD3/TCR-signaling complex in CD73-mediated signal transduction. A transmembrane form of CD73 was expressed in Jurkat cells by fusing the extracellular portion of CD73 to the transmembrane domain of human tissue factor. Although as a group, clones expressing transmembrane CD73 synthesized less IL-2 in response to CD73 mAb + PMA than clones expressing the GPI-anchored form of the molecule, the responses of the two groups overlapped considerably. In contrast to previous studies with Ly-6, Qa-2, and CD55, the GPI anchor is not critical for activation through CD73.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
153
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1046-53
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:8027539-5'-Nucleotidase,
pubmed-meshheading:8027539-Amino Acid Sequence,
pubmed-meshheading:8027539-Base Sequence,
pubmed-meshheading:8027539-Cell Line,
pubmed-meshheading:8027539-DNA Primers,
pubmed-meshheading:8027539-Genetic Vectors,
pubmed-meshheading:8027539-Glycosylphosphatidylinositols,
pubmed-meshheading:8027539-Humans,
pubmed-meshheading:8027539-Lymphocyte Activation,
pubmed-meshheading:8027539-Molecular Sequence Data,
pubmed-meshheading:8027539-Receptors, Antigen, T-Cell, alpha-beta,
pubmed-meshheading:8027539-Signal Transduction,
pubmed-meshheading:8027539-Transfection
|
pubmed:year |
1994
|
pubmed:articleTitle |
Glycosyl phosphatidylinositol membrane anchor is not required for T cell activation through CD73.
|
pubmed:affiliation |
Immunobiology and Cancer Program, Oklahoma Medical Research Foundation, Oklahoma City 73104.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, U.S. Gov't, P.H.S.
|